Skip to main
INTS

INTS Earnings Dates & Reports

INTS Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$1.14
Actual EPS-$0.96
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

INTS Earnings per Share (EPS) History

Signup for full access
Browse free

INTS Latest Earnings

The value each INTS share was expected to gain vs. the value each share gained.

INTS reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.96. This exceeded analysts' expectations of -$1.14 by 15.79%, marking a Beat.

For comparison, Intensity Therapeutics Inc reported EPS of -$5.50 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.68.

INTS Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.68
Q1 2026
-$1.14-$0.96-15.79%
Q4 2025
-$1.29-$1.31+1.55%
Q3 2025
-$1.50-$1.500.00%
Q2 2025
-$4.50-$3.25-27.78%
View all

INTS Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Intensity Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

INTS Earnings FAQs

INTS last reported earnings on May 7, 2026 for Q1 2026, posting an EPS of -$0.96, which Beat the estimate of -$1.14 by 15.79%.

For Q1 2026, INTS reported an EPS of -$0.96, exceeding analysts' estimate of -$1.14 by 15.79%.

For Q1 2026, INTS Beat expectations with an actual EPS of -$0.96 vs. an estimated EPS of -$1.14.

Following the last earnings report on May 7, 2026, INTS's stock price moved — from — to —.

The next INTS earnings call is scheduled for Aug. 6, 2026, where executives will discuss financial results and outlook.

Intensity Therapeutics Inc (INTS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.